Notes
Merck Sharp & Dohme
Reference
PHARMAC. Evolution of evidence underpins PHARMAC's pembrolizumab funding decision. Internet Document : 2 Aug 2016. Available from: URL: https://www.pharmac.govt.nz/news/media-2016-08-02-pembrolizumab/
Rights and permissions
About this article
Cite this article
PHARMAC announces funding of pembrolizumab. PharmacoEcon Outcomes News 759, 33 (2016). https://doi.org/10.1007/s40274-016-3298-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3298-4